Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 7,772,000 | 7,797,000 | 7,451,000 | 7,456,000 | 7,165,000 |
| Cost of Goods | 2,028,000 | 1,852,000 | 1,767,000 | 1,929,000 | 1,793,000 |
| Gross Profit | 5,744,000 | 5,945,000 | 5,684,000 | 5,527,000 | 5,372,000 |
| Operating Expenses | 3,603,000 | 3,782,000 | 3,630,000 | 7,121,000 | 2,732,000 |
| Operating Income | 2,141,000 | 2,163,000 | 2,054,000 | -1,594,000 | 2,640,000 |
| Interest Expense | 74,000 | 86,000 | 65,000 | 86,000 | 89,000 |
| Other Income | -381,000 | -891,000 | -7,000 | -1,285,000 | -22,000 |
| Pre-tax Income | 1,686,000 | 1,186,000 | 1,982,000 | -2,965,000 | 2,529,000 |
| Income Tax | 432,000 | 261,000 | 534,000 | -1,428,000 | 749,000 |
| Net Income Continuous | 50,000 | 1,170,000 | 1,699,000 | -954,000 | 1,999,000 |
| Minority Interests | -114,000 | -111,000 | -121,000 | -110,000 | -111,000 |
| Net Income | $1,419,000 | $1,059,000 | $1,578,000 | $-1,064,000 | $1,888,000 |
| EPS Basic Total Ops | 1.09 | 0.81 | 1.21 | -1.15 | 1.45 |
| EPS Basic Continuous Ops | 1.09 | 0.81 | 1.21 | -1.15 | 1.45 |
| EPS Diluted Total Ops | 1.09 | 0.81 | 1.21 | -1.15 | 1.45 |
| EPS Diluted Continuous Ops | 1.09 | 0.81 | 1.21 | -1.15 | 1.45 |
| EBITDA(a) | $2,633,000 | $2,183,000 | $2,941,000 | $480,000 | $2,659,000 |